Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2020-12-15
2021-10-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AP collagen peptide
Each subject takes one active bottle per day for 12 weeks. Each bottle contains AP collagen 1000 mg
AP collagen peptide
Health functional food
Placebo
Each subject takes one active bottle per day for 12 weeks.
Placebo
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AP collagen peptide
Health functional food
Placebo
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Those whose moisture retention in both cheeks measured by Corneometer® is 49 A.U. or less
* A person who has agreed to participate in this human application test before the start of the human application test and filled out the Informed Consent Form
Exclusion Criteria
* Those who are sensitive to or allergic to the food ingredients for this trial foods
* Those with skin abnormalities such as spots, acne, erythema, and hypersensitive skin at the test site
* People who take diet pills (absorbent and antidepressants, appetite suppressants, etc.) and contraceptives or hormones or diuretics within one month based on visit1
* Those who have used functional cosmetics for wrinkle improvement, highly moisturizing cosmetics, or skincare devices within 2 weeks of visit 1
* A person who used steroid-containing outer skin for more than one month to treat skin diseases
* A person who has received chemical and physical treatment (pattern, epidermis, lasers, procedures, etc.) in the test area within six months prior to the start of the test
* Visit 1 A person who has participated in other interventional clinical tests (including human application tests) within one month of the standard or plans to participate in other interventional clinical tests (including human application tests) after the start of this human application test
* A person who judges that the tester is inappropriate for this test
35 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amorepacific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hae Kwang Lee, PhD
Role: PRINCIPAL_INVESTIGATOR
P&K Skin Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
P&K Skin Research Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PNK-20D21-FF1R
Identifier Type: -
Identifier Source: org_study_id